FiercePharma

@FiercePharma

Join 160,000 pharma insiders on our free newsletter at .

West End, District of Columbia
Joined December 2008

Tweets

You blocked @FiercePharma

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @FiercePharma

  1. Aug 6

    Spectrum's Rolontis, angling to rival Amgen's Neulasta, hit with FDA rejection over manufacturing 'deficiencies'

    Undo
  2. Aug 6

    GSK again scores $235M in 'skinny label' case, but court admits it's 'unclear what Teva even did wrong'

    Undo
  3. Aug 6

    Sanofi and Regeneron solidify Dupixent TV ad lead, topping July pharma spenders again, trailed by AbbVie and Novo Nordisk

    Undo
  4. Aug 6

    While Novo's GLP-1 meds post big gains, the company is still looking to create an insulin 'revolution,' CEO says

    Undo
  5. Aug 6

    AstraZeneca chief Soriot lends GlaxoSmithKline's Walmsley CEO wisdom, support as activist investors press for change

    Undo
  6. Aug 5

    How's Amgen's key KRAS launch looking? It's too early for meaningful sales, but expectations are riding high

    Undo
  7. Aug 5

    Pfizer, Flynn face revived U.K. antitrust accusations of 'unfairly high' prices on epilepsy drug

    Undo
  8. Aug 5

    Sanofi, Regeneron stop Libtayo-chemo lung cancer trial early on strong survival data

    Undo
  9. Aug 5

    Regeneron's COVID-19 antibodies rake in $2.6B, reflecting their market dominance and blowing away estimates

    Undo
  10. Aug 5
    Undo
  11. Aug 5

    'The kidney medicine': Bayer touts Kerendia's blockbuster potential as its pharma group swings back to growth

    Undo
  12. Aug 5

    Moderna, citing variants and waning immunity, expects COVID-19 boosters to become a fact of life

    Undo
  13. Aug 4

    Social media mavens join SK Life Science's latest epilepsy awareness campaign to promote zero seizures goal

    Undo
  14. Aug 4
    Undo
  15. Aug 4

    Pfizer, Moderna and Alnylam flag pharma labor shortage in Massachusetts—and the people bottleneck doesn't stop there

    Undo
  16. Aug 4

    Amgen vows to fight after IRS demands $3.6B in back taxes—and a bigger bill could be on the way

    Undo
  17. Aug 3

    AstraZeneca's launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program

    Undo
  18. Aug 3

    Bristol Myers pulls an Istodax lymphoma use 10 years after FDA accelerated approval

    Undo
  19. Aug 3

    BeiGene lays plans for 'flagship' biologics plant and R&D center in New Jersey

    Undo
  20. Aug 3
    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·